{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:20:08Z","timestamp":1762928408757},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.therap.2016.03.003","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T14:17:05Z","timestamp":1463062625000},"page":"501-506","source":"Crossref","is-referenced-by-count":3,"title":["Impact de l\u2019avis du Haut conseil \u00e0 la sant\u00e9 publique du 28 septembre 2012 \u00e0 propos de la vaccination antipapillomavirus\u00a0: une \u00e9tude de l\u2019\u00e9volution de la co-d\u00e9livrance des vaccins antipapillomavirus et vaccin tri ou t\u00e9travalent DTP ou DTCP en Midi-Pyr\u00e9n\u00e9es"],"prefix":"10.1016","volume":"71","author":[{"given":"Jordan","family":"Birebent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Dupouy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Roussel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Bourrel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Bismuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Oustric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2016.03.003_bib0120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"issue":"6","key":"10.1016\/j.therap.2016.03.003_bib0125","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Mu\u00f1oz","year":"2003","journal-title":"N Engl J Med"},{"issue":"5A","key":"10.1016\/j.therap.2016.03.003_bib0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0002-9343(97)00177-0","article-title":"Epidemiology of genital human papillomavirus infection","volume":"102","author":"Koutsky","year":"1997","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.therap.2016.03.003_bib0135","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/sj.bjc.6602049","article-title":"Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort","volume":"91","author":"Peto","year":"2004","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.therap.2016.03.003_bib0140","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/jcp.2004.024570","article-title":"Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology","volume":"59","author":"Kulmala","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.therap.2016.03.003_bib0145","series-title":"Estimation nationale de l\u2019incidence et de la mortalit\u00e9 par cancer en France entre 1980 et 2012. Partie 1\u00a0\u2013\u00a0Tumeurs solides","author":"Binder Foucard","year":"2013"},{"issue":"4","key":"10.1016\/j.therap.2016.03.003_bib0150","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1086\/315805","article-title":"Concurrent and sequential acquisition of different genital human papillomavirus types","volume":"182","author":"Thomas","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.therap.2016.03.003_bib0155","series-title":"Cervarix et Gardasil\u00a0: \u00e9volution des modalit\u00e9s de remboursement selon le calendrier vaccinal en vigueur","author":"Vidal","year":"2013"},{"key":"10.1016\/j.therap.2016.03.003_bib0160","series-title":"Vaccination contre les infections \u00e0 papillomavirus humains des jeunes filles de 14 \u00e0 23ans","author":"Haut conseil \u00e0 la sant\u00e9 publique","year":"2010"},{"issue":"5","key":"10.1016\/j.therap.2016.03.003_bib0165","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1542\/peds.2006-0461","article-title":"Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women","volume":"118","author":"Block","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.therap.2016.03.003_bib0170","volume":"8\/9","author":"Fonteneau","year":"2013","journal-title":"BEH"},{"key":"10.1016\/j.therap.2016.03.003_bib0175","series-title":"Vaccination contre les infections \u00e0 papillomavirus humain","author":"Haut conseil de la sant\u00e9 publique","year":"2014"},{"issue":"35","key":"10.1016\/j.therap.2016.03.003_bib0180","first-page":"19","article-title":"Vaccins papillomavirus\u00a0: bilan 2014 des effets ind\u00e9sirables","volume":"375","author":"La Revue Prescrire","year":"2015","journal-title":"Rev Prescrire"},{"issue":"1","key":"10.1016\/j.therap.2016.03.003_bib0185","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00404-013-2955-0","article-title":"Pregnancy outcome following loop electrosurgical excision procedure (LEEP) a systematic review and meta-analysis","volume":"289","author":"Jin","year":"2014","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.therap.2016.03.003_bib0190","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.gyobfe.2011.10.016","article-title":"Perception and psychological impact of an abnormal Pap smear. Results of a comparative European survey","volume":"40","author":"Monsonego","year":"2012","journal-title":"Gynecol Obstet Fertil"},{"issue":"4","key":"10.1016\/j.therap.2016.03.003_bib0195","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/pds.1717","article-title":"Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study","volume":"18","author":"Noize","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"10.1016\/j.therap.2016.03.003_bib0200","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.respe.2014.03.001","article-title":"Impact de la modification d\u2019avis du Haut Conseil de la sant\u00e9 publique (HCSP) sur le taux de prescription des vaccins papillomavirus humains en r\u00e9gion Midi-Pyr\u00e9n\u00e9es","volume":"62","author":"Birebent","year":"2014","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.therap.2016.03.003_bib0205","first-page":"31","article-title":"La formation m\u00e9dicale continue des m\u00e9decins fran\u00e7ais. Quelques donn\u00e9es sur la situation actuelle","volume":"32","author":"Gallois","year":"2000","journal-title":"ADSP"},{"key":"10.1016\/j.therap.2016.03.003_bib0210","first-page":"1805","article-title":"Les vaccins des papillomavirus humains. Leur place dans la pr\u00e9vention du cancer du col ut\u00e9rin","volume":"191","author":"B\u00e9gu\u00e9","year":"2007","journal-title":"Bull Acad Natle Med"},{"issue":"32","key":"10.1016\/j.therap.2016.03.003_bib0215","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1016\/j.vaccine.2011.05.006","article-title":"Human papillomavirus vaccination: perception and practice among French general practitioners in the year since licensing","volume":"29","author":"Lutringer-Magnin","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.therap.2016.03.003_bib0220","unstructured":"Murat N. La diffusion du vaccin antipapillomavirus a-t-elle modifi\u00e9 la prise en charge des adolescentes en m\u00e9decine g\u00e9n\u00e9rale. [Th\u00e8se M\u00e9decine]. Toulouse; 2012. http:\/\/www.sudoc.abes.fr\/DB=2.1\/SRCH?IKT=12&TRM=163547750. [Consult\u00e9 le 2 mai 2016]."},{"key":"10.1016\/j.therap.2016.03.003_bib0225","unstructured":"Fiquet-Peuch J. Les r\u00e9ticences des patients \u00e0 la vaccination. Approche du ressenti des patients. \u00c9tude sur 3 vaccinations particuli\u00e8res. [Th\u00e8se M\u00e9decine]. Toulouse; 2014. http:\/\/thesesante.ups-tlse.fr\/419\/. [Consult\u00e9 le 2 mai 2016]."},{"issue":"362","key":"10.1016\/j.therap.2016.03.003_bib0115","first-page":"928","article-title":"Vaccin papillomavirus d\u00e8s 11ans\u00a0: sans raison valable","volume":"33","author":"La Revue Prescrire","year":"2013","journal-title":"Rev Prescrire"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716300336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716300336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T07:54:44Z","timestamp":1554278084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716300336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0040595716300336"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2016.03.003","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}